There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 123-00-2 | MDL No. : | MFCD00006184 |
Formula : | C7H16N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UIKUBYKUYUSRSM-UHFFFAOYSA-N |
M.W : | 144.21 | Pubchem ID : | 61055 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.25 |
TPSA : | 38.49 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.67 cm/s |
Log Po/w (iLOGP) : | 1.88 |
Log Po/w (XLOGP3) : | -0.69 |
Log Po/w (WLOGP) : | -0.71 |
Log Po/w (MLOGP) : | -0.31 |
Log Po/w (SILICOS-IT) : | 0.56 |
Consensus Log Po/w : | 0.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.1 |
Solubility : | 114.0 mg/ml ; 0.792 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.36 |
Solubility : | 328.0 mg/ml ; 2.27 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -0.9 |
Solubility : | 18.2 mg/ml ; 0.126 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Danger | Class: | 8 |
Precautionary Statements: | P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501 | UN#: | 2735 |
Hazard Statements: | H302-H314 | Packing Group: | Ⅲ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
22% | With sodium tetrahydroborate; hydrogen; nickel dichloride In <i>tert</i>-butyl alcohol at 70℃; for 8 h; | Similarly to the described above, using sodium borohydride (0.6 g, 0.016 mol), 15 mL of tert-butanol, anhydrous nickel(II) chloride (1.0 g, 0.008 mol), and nitrile 1n (14 g, 0.1 mol). The reaction duration was 8h, the temperature was 70°C. Morpholine 9n, content 22 wt percent. Mass spectrum, m/e (Irel, percent): 88.8 (2) [ M+2], 87.9 (59) [ M+ 1], 86.8 (67) [M], 86.0 (100), 56.9(86), 55.9 (98), 41.9 (28). 3-N-Morpholino-1-aminopropane 2n, content 59 wt percent. Mass spectrum, m/e(Irel, percent): 145.0 (5) [ M+ 1], 128.0 (1.5), 126.8 (7),113.0 (32), 101.0 (11), 100.0 (100), 86.0 (7), 72.0 (10),70.0 (30), 57.0 (11), 56.0 (35), 42.0 (30). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With N-ethyl-N,N-diisopropylamine In iso-butanol at 120℃; for 0.5 h; Microwave irradiation | 4Synthesis of EHop-016 [0031] 1H and 13C NMR spectra were recorded on a Bruker 400 MHz Spectrometer. Mass spectra were obtained on a Hewlett Packard 6890N GC/MS Spectrometer. All chemicals were purchased from Sigma Aldrich Chemical Company. The synthesis of EHop-016 (5) was performed in two steps according to the reaction scheme provided in FIG. 1(A), and carried out analogous to the procedure described in (58). (2-Chloro-pyrimidin-4-yl)-(9-ethyl-9H-carbazol-3-yl)-amine 3 was obtained as a pure compound in a yield of 53percent. The product was identified with TLC, NMR and GC/MS. Rf=0.23 (3:1, Hexane-Ethyl Acetate); 1H NMR (DMSO-d6, 400 MHz) δ 1.32 (t, J=6.9 Hz, 3H), 4.45 (q, J=6.6 Hz, 2H), 6.72 (s, 1H), 7.20 (t, J=7.36 Hz, 1H), 7.47 (t, J=7.30 Hz, 1H), 7.56 (s, 1H), 7.62 (t, J=8.68 Hz, 1H), 8.11 (t, J=7.36 Hz, 1H), 8.27 (s, 1H), 10.1 (s, 1H); 13C (DMSO-d6, 100 MHz) δ 13.7, 37.0, 109.2, 109.4, 115.0, 118.7, 120.3, 121.3, 121.9, 122.3, 125.9, 129.9, 136.9, 140.0, 156.9, 159.6, 162.4; LRGC-MS m/z (rel percent):[M]+ 276 (100), [M-Cl]+ 241 (40), [M-C5H5N3Cl]+ 134 (26). N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-yl-propyl)-pyrimidine-2,4-diamine 5 (EHop-016) was obtained as a pure compound in a yield of 93percent. The product was identified to be essentially pure by TLC and NMR: Rf=0.34 (9:1, CH2Cl2—MeOH); 1H NMR (DMSO-d6, 400 MHz) δ 1.31 (t, J=7.0 Hz, 3H), 1.73 (m, 2H), 2.32 (m, 2H), 2.34 (t, J=6.89 Hz, 8H), 3.52 (m, 2H), 4.42 (q, J=7.0 Hz, 2H), 5.98 (d, J=5.7 Hz, 1H), 6.69 (t, J=5.3 Hz, 1H), 7.16 (t, J=7.4, 1H), 7.43 (t, J=7.2 Hz, 1H), 7.53 (t, J=9.0 Hz, 4H), 7.81 (d, J=5.4 Hz, 1H), 8.10 (s, 1H), 8.66 (s, 1H), 9.1 (s, 1H); 13C (DMSO-d6, 100 MHz) δ 13.7, 26.2, 36.9, 53.4, 56.3, 66.2, 108.9, 109.0, 118.2, 119.7, 120.2, 122.0, 122.2, 125.6, 132.5, 135.5, 139.9, 159.8, 160.9, 162.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With potassium carbonate; In acetone; at 20℃; for 2.25h; | Example 6 <n="15"/>Preparation of 4-acetamido-N-(3-morpholinopropyl)benzenesulphonamide XIII; [Goldberg, M. W., Moutclair, U., US. Pat. 2.879.293 (1959)]To the solution of 2.8 g (0.020 mol) of 3-morpholinopropylamine in 15 ml of acetone, the solution of 3.3 g (0.024 mol) of potassium carbonate in 3 ml of water was added under stirring. To this mixture, 5 g (0.021 mol) of 4-acetamidobenzenesulphonyl chloride XII was added portionwise at the room temperature for 15 min. The mixture was then stirred at the room temperature for another 2 hours. One half of the solvent volume was distilled off from the mixture, the mixture was cooled to 0 0C, Obtained solid was separated, washed 3 times with 5 ml of ice water and dried. Afforded 4,2 g (62 %) of 4-acetamido-N-(3-morpholinopropyl)benzenesulphonamide XIII, colourless solid, m.p. 97-98 0C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; | EXAMPLE 8: Preparation of 3- (3-lNo.-indol-3-yl-acryloylamino) -N- (3-morpholin-4-yl-propyl) -benzamide; In 5.0 mL of dimethylformamide were dissolved 3-(3-1H- indol-3-yl-acryloylamino) -benzoic acid (150 mg, 0.49 mmol) , prepared in Example 3, and 3-morpholin-4-yl-propylamine (0.11 mL, 0.73 mmol), followed by the addition of O- (7- azabenzotriazol-1-yl) -N, N, N' , N' -tetramethyl uronium <n="31"/>hexafluorophosphate (277.6 mg, 0.73 rnmol) and N,N- diisopropylethylamine (0.13 ml, 0.73 mmol) . The resulting solution was stirred at room temperature and mixed with ethyl acetate and an aqueous sodium salt solution. The organic layer was dried over anhydrous magnesium sulfate. After the filtration and concentration of the residue, the concentrate was purified using Prep-TLC (methylene chloride:methanol = 10:1) to produce the subject compound as a yellow solid (8)(92.6 mg, 44%) . 1H-NMR (DMSO-de, 300Hz): 11.66 (IH, brs, aromatic), 10.14(IH, s, aromatic), 8.46(1H, ps t, J= 5.4 Hz, aromatic), 8.09(IH, s, aromatic), 7.76-7.98 (4H, m, aromatic), 7.37-7.50 (3H, m, aromatic), 7.22 (2H, m, aromatic), 6.82 (IH, d, J = 15.9 Hz, aromatic), 3.55-3.59 (4H, m, aliphatic), 3.27 (IH, m, aliphatic), 3.16 (IH, d, J = 15.9 Hz, aliphatic), 2.31-2.36(6H, m, aliphatic) 1.69 (2H, m, aliphatic). |
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; | 1-15. Synthesis of low-molecular-weight compound ID-265 (10c) The low-molecular-weight compound ID-265 (3-(3-1H-indol-3-yl-acrylamino)-N-(3-morpholin-4-yl-propyl)-benzamide) was prepared in the following manner. 3-(3-1H-indol-3-yl-acryloylamino)-benzoic acid (9, 150 mg, 0.49 mmol) and 3-morpholin-4-yl-propylamine (0.11 mL, 0.73 mmol) were dissolved in DMF, and HATU (277.6 mg, 0.73 mmol) and DIPEA (0.13 mL, 0.73 mmol) were added thereto. The reaction solution was stirred overnight at room temperature. The resulting material was separated and purified to obtain 3-(3-1H-indol-3-yl-acryloylamino)-N-(3-morpholin-4-yl-propyl)-benzamide (ID-265) as a yellow solid. 1H NMR (DMSO-d3, 300 MHz) d = 11.66 (b, 1H), 10.14 (s, 1H), 8.46 (ps-t, J = 5.4 Hz, 1H), 8.09 (s, 1H), 7.76-7.98 (m, 4H), 7.37-7.50 (m, 3H), 7.22 (m, 2H), 6.82 (d, J = 15.9 Hz, 1H), 3.55-3.59 (m, 4H), 3.27 (m, 1H), 3.16 (d, J = 15.9 Hz, 1H), 2.31-2.36 (m, 6H) 1.69 (m, 2H). | |
With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; | 1-15. Synthesis of Low-Molecular-Weight Compound ID-265 (10c) The low-molecular-weight compound ID-265 (3-(3-1H-indol-3-yl-acrylamino)-N-(3-morpholin-4-yl-propyl)-benzamide) was prepared in the following manner. 3-(3-1H-indol-3-yl-acryloylamino)-benzoic acid (9, 150 mg, 0.49 mmol) and 3-morpholin-4-yl-propylamine (0.11 mL, 0.73 mmol) were dissolved in DMF, and HATU (277.6 mg, 0.73 mmol) and DIPEA (0.13 mL, 0.73 mmol) were added thereto. The reaction solution was stirred overnight at room temperature. The resulting material was separated and purified to obtain 3-(3-1H-indol-3-yl-acryloylamino)-N-(3-morpholin-4-yl-propyl)-benzamide (ID-265) as a yellow solid. 1H NMR (DMSO-d3, 300 MHz) d=11.66 (b, 1H), 10.14 (s, 1H), 8.46 (ps-t, J=5.4 Hz, 1H), 8.09 (s, 1H), 7.76-7.98 (m, 4H), 7.37-7.50 (m, 3H), 7.22 (m, 2H), 6.82 (d, J=15.9 Hz, 1H), 3.55-3.59 (m, 4H), 3.27 (m, 1H), 3.16 (d, J=15.9 Hz, 1H), 2.31-2.36 (m, 6H) 1.69 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
This aldehyde was reacted with 4-(3-aminopropyl)morpholine by the procedure of example 1(c) to afford the title compound as a yellow oil. 1 H NMR (CD3 Cl): delta8.45 (d, J=5.1 Hz, 1H), 8.24 (s, 1H), 7.63 (s, 1H); 7.51 (d, J=5.1 Hz, 1H), 3.72 (m, 6H), 2.44 (m, 6H), 1.91 (m, 2H). | ||
This aldehyde was reacted with 4-(3-aminopropyl)morpholine by the procedure of example 1(c) to afford the title compound as a yellow oil. 1 H NMR (CD3 Cl): delta8.45 (d, J=5.1 Hz, 1H), 8.24 (s, 1H), 7.63 (s, 1H); 7.51 (d, J=5.1 Hz, 1H), 3.72 (m, 6H), 2.44 (m, 6H), 1.91 (m, 2H). | ||
This aldehyde was reacted with 4-(3-aminopropyl)morpholine by the procedure of example 1(c) to afford the title compound as a yellow oil. 1 H NMR (CD3 Cl): delta 8.45 (d, J=5.1 Hz, 1H), 8.24(s, 1H),7.63 (s, 1H); 7.51 (d, J=5.1Hz, 1H), 3.72 (m, 6H), 2.44 (m, 6H), 1.91 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | 2-methoxy-4-nitro-benzoic acid (3.0 g, 15.5 MMOL) was dissolved in THF (180 ML) and the mixture was heated to reflux (70 C). CARBONYL DIIMIDAZOL (3.7 g, 22.8 MMOL) was added in 3 portions with 20 minutes intervals-with continued refluxing. After the last addition reaction is allowed to reflux for another 1 h. The reaction mixture was cooled to room temperature followed by addition of 3-morpholin-4-yl-propylamine (4.4 g, 30.4 MMOL) and the reaction was left overnight. The solvent was removed in vacuo and to the crude product was added a mixture of 200 ML EtOAc and 200 ml of water. The organic phase is washed with 2*200 ml water and 1 *200 ML of brine. The combined organic phases was dried over MGS04 AND concentrated giving a clear oil. Crystallisation can be obtained by adding diethylether followed by evaporation. The product (7.6 g, 23 MMOL) was dissolved in methanol (120 ml) and 10 % Pd/C (40 mg) was added. A pressure of hydrogen atmosphere was applied and the reaction was left over night. Filtration through a plug of celite gave 7.36 g of the title product (94 % over all yield). 'H-NMR (300 MHz, CD3CI) : S 1H, 7.79 (s, 1H), 4.03 (s, 2H), 3.90 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With triethylamine; In dichloromethane; at 20℃; for 1h; | A suspension of 10a (110 mg, 0.33 mmol) in methylene chloride (10 mL) was treated with 4-(3-morpholino)-1-propylamine (240 mg, 1.66 mmol) and triethylamine (1 eq), and the reaction mixture was stirred at room temperature for 1 h. The resulting mixture was diluted with ethyl acetate, and the solid that precipitated was filtered, washed with ether and dried to provide compound 11a. Yield=65 mg (45%). |
45% | With triethylamine; In dichloromethane; at 20℃; for 1h; | 5-123f) 5-Oxo-5,7-dihydro-6H-indeno[2,1-c]isoquinoline-9-sulfonic acid (3-morpholin-4-yl-propyl)-amide (11a) (Scheme 1-123) A suspension of 10a (110 mg, 0.33 mmol) in methylene chloride (10 mL) was treated with 4-(3-morpholino)-1-propylamine (240 mg, 1.66 mmol) and triethylamine (1 eq), and the reaction mixture was stirred at room temperature for 1 h. The resulting mixture was diluted with ethyl acetate, and the solid that precipitated was filtered, washed with ether and dried to provide compound 11a. Yield=65 mg (45%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With 1,1'-carbonyldiimidazole; In tetrahydrofuran; at 20℃; for 36h; | Example 53 Preparation of 5-(4-fluorophenoxy)-1-isobutyl-1H-indazole-6-carboxylic acid (3-morpholin-4-yl-propyl)-amide (11g-8) A solution of 5-(4-fluorophenoxy)-1-isobutyl-1H-indazole-6-carboxylic acid (compound 10g, prepared as described in Example 46) in THF was treated with carbonyldiimidazole (1.2 equivalents) at room temperature under nitrogen atmosphere.After stirring for 18 hours, the reaction was treated with 3-morpholin-4-yl-propylamine (1 equivalent).After an additional 18 hours, the solvent was allowed to slowly evaporate and the residue was purified in a Sep Pak cartridge eluding with a gradient of 100% CH2Cl2 to 5% MeOH/CH2Cl2 to provide compound 11g-8 as an oil in 70% yield. |
70% | With 1,1'-carbonyldiimidazole; In tetrahydrofuran; dichloromethane; | Example 53 Preparation of 5-(4-fluorophenoxy)-1-isobutyl-1H-indazole-6-carboxylic acid (3-morpholin-4-yl-propyl)-amide (11g-8) A solution of 5-(4-fluorophenoxy)-1-isobutyl-1H-indazole-6-carboxylic acid (compound 10g, prepared as described in Example 46) in THF was treated with carbonyldiimidazole (1.2 equivalents) at room temperature under nitrogen atmosphere. After stirring for 18 hours, the reaction was treated with 3-morpholin-4-yl-propylamine (1 equivalent). After an additional 18 hours, the solvent was allowed to slowly evaporate and the residue was purified in a Sep Pak cartridge eluding with a gradient of 100% CH2Cl2 to 5% MeOH/CH2Cl2 to provide compound 11g-8 as an oil in 70% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With triethylamine; In dichloromethane; at 0 - 20℃; for 0.5h; | 4-Iodophenylsulphonyl chloride (3.03 g, 10 mmol) in DCM (30 ml) was added dropwise over 15 minutes to a solution of 4-(3-aminopropyl)morpholine (1.75 ml, 12 mmol) and triethylamine (1.7 ml, 12 mmol) in DCM (50 ml) cooled in an ice bath. The mixture was allowed to warm to ambient temperature and stirred for 15 minutes. Water (50 ml) was added and the phases separated. The organic layer was washed with water (50 ml) and brine (50 ml), dried (Chemelut column 1010) and evaporated to give the title compound (4.10 g, 100%) as a beige solid. NMR 1.70 (m, 21), 2.43 (m, 61, 3.14 (t, 2H), 3.71 (m, 4H), 7.08 (s, 1H), 7.58 (d, 2H), 7.85 (d, 2H); m/z 411. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 80℃; for 3h; | Intermediate 36; (5-Bromo-pyrimidin-2-yl)-(3-morpholin-4-yl-propyl)-amine2-Chloro-5-bromopyrimidine (50 g) was added to propan-2-ol (300 mL), DIPEA (92 mL) and aminopropylmorpholine (46 mL) and the reaction was heated at 8O0C for 3 hours. The reaction was allowed to cool and the solvent removed in vacuo to yield an orange gum, this was quenched with water (200 mL), extracted with diethyl ether (3 x 600 mL), dried(MgSO4) and solvent removed in vacuo to yield a yellow viscous oil. Diethyl ether (100 mL) was rapidly added to the gum with scratching until a solid crashed out, this was filtered. Process repeated on the filtered mother liquor until no solid crashed out. The obtained solids were combined and stirred in iso-hexane (200 mL) for 20 mins before being filtered and dried. White solid obtained (67g, 86%);1H NMR (300.072 MHz, cdcl3) delta 8.25 (s, 2H), 6.02 (s, IH), 3.73 (t, 4H), 3.45 (q, 2H), 2.49 - 2.44 (m, 6H), 1.78 (quintet, 2H); MS m/e MH+ 302. |
86% | With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 80℃; for 3h; | (5-Bromo-pyrimidin-2-yl)-(3-morpholin-4-yl-propyl)-amine 2-Chloro-5-bromopyrimidine (50 g) was added to propan-2-ol (300 mL), DIPEA (92 mL) and aminopropylmorpholine (46 mL) and the reaction was heated at 80 C. for 3 hours. The reaction was allowed to cool and the solvent removed in vacuo to yield an orange gum, this was quenched with water (200 mL), extracted with diethyl ether (3*600 mL), dried (MgSO4) and solvent removed in vacuo to yield a yellow viscous oil. Diethyl ether (100 mL) was rapidly added to the gum with scratching until a solid crashed out, this was filtered. Process repeated on the filtered mother liquor until no solid crashed out. The obtained solids were combined and stirred in iso-hexane (200 mL) for 20 mins before being filtered and dried. White solid obtained (67 g, 86%); 1H NMR (CDCl3) delta 8.25 (s, 2H), 6.02 (s, 1H), 3.73 (t, 4H), 3.45 (q, 2H), 2.49-2.44 (m, 6H), 1.78 (quintet, 2H); MS m/e MH+302. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With triethylamine; In dichloromethane; at 25℃; | Into a 100-mL round-bottom flask, was placed a solution of 3-morpholinopropan-1-amine (5 g, 34.67 mmol, 1.00 equiv) in dichloromethane (50 mL), di-tert-butyl dicarbonate (7.56 g, 34.67 mmol, 1.00 equiv.), triethylamine (7 g, 70.00 mmol, 2.00 equiv). The resulting solution was stirred overnight at 25 C. The resulting mixture was concentrated under vacuum. This resulted in 6.8 g (80%) of tert-butyl 3-morpholinopropylcarbamate as light yellow oil. |
In dichloromethane; | A. To a solution of 4-(3-aminopropyl)morpholine (50.0 g, 0.347 mol) in CH2Cl2 (250 mL) at approximately 0 C. was added a solution of Di-tert-butyl dicarbonate (75.5 g, 0.347 mol) in CH2Cl2 (250 mL). The reaction mixture was stirred at 0 C. for 1 hour then at room temperature for 14 hours. The reaction mixture was then washed with saturated aqueous NaHCO3 and water. The organic layer was then dried over Na2SO4, filtered and the filtrate concentrated in vacuo to provide 4-(3-(tert-butoxycarbonylamino)propyl)morpholine as a clear oil. 1H-NMR (300 MHz, DMSO-d6): delta 6.75 (t, 1H, J=7 Hz), 3.53 (t, 4H, J=5 Hz), 2.91 (q, 2H, J=7 Hz), 2.29 (t, 4H, J=5 Hz), 2.22 (t, 2H, J=7 Hz), 1.35 (s, 9H). | |
With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; | 3-(4-Morpholinyl)propan-1-amine (35.0 g, 243 mmol) was dissolved in tetrahydrofuran (THF, 250 mL), di-tert-butyl dicarbonate (58.0 g, 266 mmol) and N,N-diisopropylethylamine (DIPEA, 84 mL, 484 mmol) were added, and the solution was stirred overnight. The solvent was removed and the residue partitioned between ethyl acetate (EA) and 1.2M hydrochloric acid (300 mL). The pH was raised to 7 with saturated aqueous sodium bicarbonate and the layers separated. The aqueous layer was extracted twice with EA (150 mL each), and the EA layers were combined, washed with brine, and dried over magnesium sulfate. The solvent was removed, giving tert-butyl 3-(4-morpholinyl)propylcarbamate (39 g). Tent-butyl 3-(4-morpholinyl)propylcarbamate (3.5 g, 14.3 mmol) was dissolved in THF (30 mL), and sodium hydride (60% dispersion in mineral oil, 1.03 g, 25.8 mmol) was added in portions. After stirring for 5 min, ethyl iodide (13.4 g, 86.0 mmol) was added and the mixture was heated to 60 C. for 7 hr then stirred at room temperature overnight. Water (5 mL) was added and the solvent removed. The residue was dissolved in EA, and the solution was washed with brine, dried over magnesium sulfate, and the solvent removed to give crude tert-butyl ethyl[3-(4-morpholinyl)propyl]carbamate (2.5 g). Purification by silica gel chromatography eluting with 92:8 dichloromethane/methanol (DCM/MeOH) gave purified tert-butyl ethyl[3-(4-morpholinyl)propyl]carbamate (1.4 g). Purified tert-butyl ethyl[3-(4-morpholinyl)propyl]carbamate (350 mg, 1.3 mmol) was dissolved in 4.0M hydrogen chloride in dioxane (5 mL, 20 mmol) and stirred for 45 min. Water was added and the solution made basic with 2M aqueous sodium hydroxide. The product was extracted into EA, and the EA extract washed with brine and dried over magnesium sulfate. Removal of the EA gave N-ethyl-3-(4-morpholinyl)propan-1-amine (50 mg). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With triethylamine; In ethanol; at 60℃; for 12h; | A mixture of f-1 (0.022 mol), f-2 (0.066 mol) and NEt3 (0.066 mol) in C2H5OH (50 ml) was stirred at 60C for 12 hours, then evaporated to dryness and taken up in CH2Cl2. EPO <DP n="32"/>The organic layer was washed with H2O, dried (over MgSO4), filtered and the solvent was evaporated to dryness. Yield: 7.4 g of f-3 (100%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | A mixture of <strong>[63071-13-6]4-chloro-2-pyridinecarboxaldehyde</strong> (200 mg, 0.0014 mol), N-(3- aminopropyl)morpholine (224 mg, 0.0015 mol), palphara-toluene sulfonic acid (134 mg, 0.00070 mol) and 3A molecular sieves was stirred at room temperature under Argon for 7 hours. Molecular sieves were filtered off, the reaction mixture was cooled down to O0C, and sodium borohydride (107 mg, 0.0028 mol) was slowly added. The mixture was stirred at room temperature for 17 hours, poured out into water and extracted with DCM. The organic layer was separated, washed with a saturated solution of hydrogen carbonate, dried (MgSO4), filtered, and the solvent was evaporated. The residue was purified by column chromatography over silica gel (40-63 mum) (eluent:DCM/MeOH/NuH3 85/15/3). The pure fractions were collected and the solvent was evaporated, yielding 230 mg (60%) of intermediate 76 as a yellow oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In pyridine; (2S)-N-methyl-1-phenylpropan-2-amine hydrate; | EXAMPLE I Preparation of 1-methyl-2-amino-N-(gamma-morpholino propyl)-4-amino-5-nitro-benzene: The formula for the reaction is: STR10 1. The method of preparation: To 18.65 g (0.1 mole) of <strong>[13852-51-2]1-methyl-2-amino-4-chloro-5-nitro-benzene</strong> dissolved in 40 cc of pyridine, add drop by drop gamma-aminopropyl morpholine and heat it to reflux (130-135 C) for 10 hours. By distillation remove the pyridine in excess and introduce drop by drop the resulting oil obtained into 300 cc of 1N hydrochloric acid. This forms a chestnut colored precipitate which is washed twice with 80 cc of ice water. 23.5 g of a dry product are recovered which is recrystallized in a mixture of alcohol water. After drying, the product melts at 85 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | A mixture of b-3 (0.069 mol) and N-propylamino-morpholine (0.207 mol) was stirred at 125C for 4 hours, and then taken up in CH2C12/CH3OH. The organic layer was washed with a 10% solution OfK2CO3 in water, dried (over MgSO4), filtered and the solvent was evaporated until dryness. The residue (37 g) was purified by column chromatography over silica gel (eluent: CH2C12/CH3OH/NH4OH 90/10/0.5; 20-45mum). The pure fractions were collected and the solvent was evaporated, yielding 16.5g of intermediate b-4 (82%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With N-ethyl-N,N-diisopropylamine; In acetonitrile; at -35 - 20℃; for 72h; | 12) (2-chloro-5-iodopyrimidine-4-yl)-(3-morpholin-4-yl-propyl)-amine:; In accordance with procedure 2, 3-morpholin-4-yl-propylamine (0.73 ml, 5 mmol) and N-ethyldiisopropylamine (1.71 ml, 10 mmol) are dissolved in 100 ml acetonitrile under argon and cooled to -35C. The solution of 2,4-dichloro-5- iodo-pyrimidine (1.37, 5.0 mmol) in 50 ml acetonitrile is then added dropwise at-35C internal temperature. Stirred 1 hr further at -30 to -20 0C, then slowly warmed up to RT and stirred for 3 days at RT.The reaction mixture is concentrated on the rotary evaporator. The residue is treated with 200 ml ethyl acetate and 75 ml sat. NaHCO3 soln., well shaken and the aqueous phase further extracted 2 x with 75 ml portions of ethyl acetate. The ethyl acetate phase is dried over Na2SO4 dried, filtered, concentrated and the residue dried at the oil pump: 1.92 g colourless and crystalline crude product.The crude product is purified by column chromatography (5Og column, mobile phase: gradient hexane: ethyl acetate 80% to 100% ethyl acetate): 1.66 g(97%).1H-NMR (400 MHz, DMSO-D6): delta 1.66 (m, 2H), 2.30 (m, 6H), 3.37 (m, 2H), 3.57(m, 4H)1 7.42 (t, 1 H), 8.27 (s, 1 H).MS: 383 (MH+). |
97% | With N-ethyl-N,N-diisopropylamine; In acetonitrile; at -35 - 20℃; for 73h; | In accordance with procedure 2, 3-morpholin-4-yl-propylamine (0.73 ml, 5 mmol) and N-ethyldiisopropylamine (1.71 ml, 10 mmol) are dissolved in 100 ml acetonitrile under argon and cooled to -35 C. The solution of <strong>[13544-44-0]2,4-dichloro-5-iodo-pyrimidine</strong> (1.37, 5.0 mmol) in 50 ml acetonitrile is then added dropwise at -35 C. internal temperature. Stirred 1 hr further at -30 to -20 C., then slowly warmed up to RT and stirred for 3 days at RT. The reaction mixture is concentrated on the rotary evaporator. The residue is treated with 200 ml ethyl acetate and 75 ml sat. NaHCO3 soln., well shaken and the aqueous phase further extracted 2× with 75 ml portions of ethyl acetate. The ethyl acetate phase is dried over Na2SO4 dried, filtered, concentrated and the residue dried at the oil pump: 1.92 g colourless and crystalline crude product. The crude product is purified by column chromatography (50 g column, mobile phase: gradient hexane: ethyl acetate 80% to 100% ethyl acetate): 1.66 g (97%). 1H-NMR (400 MHz, DMSO-D6): delta 1.66 (m, 2H), 2.30 (m, 6H), 3.37 (m, 2H), 3.57 (m, 4H), 7.42 (t, 1H), 8.27 (s, 1H). MS: 383 (MH+). |
97% | With N-ethyl-N,N-diisopropylamine; In acetonitrile; at -35 - 20℃; for 73h; | In accordance with GP 2, 3-morpholin-4-yl-propylamine (0.73 ml, 5 mmol) and N- ethyldiisopropylamine (1.71 ml, 10 mmol) were dissolved in 100 ml acetonitrile under argon and cooled to -35 C. The solution of <strong>[13544-44-0]2,4-dichloro-5-iodo-pyrimidine</strong> (1.37, 5.0 mmol) in 50 ml acetonitrile was then added dropwise at -35C internal temperature. Stirred 1 hr further at -30 to -20 C, then slowly warmed up to RT and stirred for 3 days at rt. The reaction mixture was concentrated on the rotary evaporator. The residue was treated with 200 ml ethyl acetate and 75 ml sat. NaHCO3 soln., well shaken and the aqueous phase further extracted 2 x with 75 ml portions of ethyl acetate. The ethyl acetate phase was dried over Na2SO4 dried, filtered, concentrated and the residue dried at the oil pump: 1.92 g colourless and crystalline crude product. The crude product was purified by column <n="119"/>chromatography (5Og column, mobile phase: gradient hexane: ethyl acetate 80% to 100% ethyl acetate): 1.66 g (97%).1H-NMR (400 MHz, DMSO-D6): 1.66 (m, 2H), 2.30 (m, 6H), 3.37 (m, 2H), 3.57 (m, 4H), 7.42 (t, 1 H), 8.27 (s, 1 H). MS: 383 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 70℃; for 20h; | <strong>[10320-42-0]<strong>[10320-42-0]2-Chloro-5-nitropyrimidin</strong>e</strong> 15 (500 mg, 3.13 mmol), 3-morpholinopropan-1-amine (1.35 g, 9.39 mmol) and DIEA (3.4 mL, 4.7 mmol) were taken up in IPA (20 mL) in a resealable pyrex tube and heated at 70° C. for 20 h. After cooling to rt, N-(3-morpholinopropyl)-5-nitropyrimidin-2-amine precipitated out of solution and was collected by filtration through a Buchner micro membrane, and washing with MeOH, then drying to afford the 5-nitro intermediate as a pale yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With potassium iodide; In N,N-dimethyl-formamide; at 80℃; for 2h; | To a solution of 4-[2-chloromethyl-1-(4-nitro-phenyl)-1H-imidazol-4-yl]-5-methyl-3-phenyl-isoxazole (50 mg, 0.13 mmol) in DMF (2 mL) was added 4-(3-aminopropyl)morpholine (36.5 mg, 0.25 mmol) and KI (4.2 mg, 0.03 mmol) and the resulting mixture heated at 80 C. for 2 h. After cooling to room temperature, the mixture was then poured onto water and extracted with ethyl acetate. The combined organic layers were then washed with brine and water and then dried over sodium sulphate and evaporated. Purification by chromatography (SiO2, dichloromethane:methanol=100:0 to 80:20) afforded the title compound (47 mg, 74%) which was obtained as a yellow gum. MS: m/e=503.4 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | In ethanol; at 120.0℃; for 16.0h; | 6-Chloroimidazo[1,2-b]pyridazine 41 (6.53 mmol) was dissolved in chloroform (12 mL) and N-chlorosuccinimide (6.53 mmol) added under N2. After stirring for 16 h, the mixture was partitioned between saturated sodium hydrogensulfate solution (25 mL) and chloroform (12 mL). The organic layer was removed, washed with water (2×), dried and concentrated to provide <strong>[40972-42-7]3,6-dichloroimidazo[1,2-b]pyridazine</strong> 5 (1.05 g, 85%) as an orange solid; 1H NMR (500 MHz, CDCl3) delta 7.92 (d, J=9.5 Hz, 1H), 7.74 (s, 1H), 7.12 (d, J=9.5 Hz, 1H). 3,6-Dichloroimidazo[1,2-b]pyridazine 5 (150 mg, 0.8 mmol) and the desired amine (1 mL) were heated in a sealed tube for 16 hr at 120 C. Upon cooling the reaction mixture was concentrated and purified by column chromatography (12 g ISCO column eluting with methylene chloride and a methanol/ammonia mixture (10:1); gradient 100% methylene chloride to 80% methylene chloride over 30 min at 25 mL/min) to provide the desired product 6. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With polymer-bound trimethyl ammonium cyanoborohydride; acetic acid; In 1,2-dichloro-ethane; at 20℃; for 24 - 36h;Combinatorial reaction / High throughput screening (HTS); | All sixty diamines were separated in four groups based on their steric and electronic characteristics, Figures 1-4. Each diamine was measured in the amount of 0.05 g (approximately 0.3 mmol) and pooled together with the others in the group. Obtained diamine mixtures were dissolved in 5 ml of 1,2-dichloroethane and used for the syntheses. Each well of the 96-well filterplates was loaded with 0.2 ml of 1: 10 mixture of acetic acid: DCE, 0.03 ml of the diamine mixture in DCE (group 1, group 2, group 3, or group 4) to assure 0.04 mmol of the diamines per well, and shaken for 5 min at room temperature. Appropriate carbonyl compounds from the master plate (0.1 ml of 1.2 M solution) were added into corresponding wells of the reaction plates followed by the addition of (polystyrylmethyl) trimethylammonium cyanoborohydride, (0.020 g, 0.08 mmol per well). The reaction plates were sealed and placed on a shaker. The reaction was allowed to proceed 24-36 hours at room temperature. At the end, the reaction mixtures were filtered using a filtration manifold, and products were collected into four (one per group) collection plates. Solvents were evaporated in SpeedVac and formed residues were analyzed by mass spectrometry prior to biological screening. Mono and double alkylated products were observed in 1: 0.5 to 1: 2 ratios by mass spectral analysis. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | A mixture of 3,3-bis(methylthio)-2-(4-trifluoromethylpyrimidin-2-yl)acrylonitrile (682 mg, 2.34 mmol), 3,4-diaminobenzoic acid (392 mg, 2.57 mmol, 1.1 eq.), and 4-dimethylaminopyridine (143 mg, 1.17 mmol, 0.5 eq.) in ethanol (3 mL) was heated at 150 C. for 0.5 hr in a microwave. The mixture was cooled to room temperature, concentrated hydrochloric acid (1 mL) was added, and the mixture was allowed to stand for 0.5 hr. The precipitate that formed was collected by filtration, washed with ethanol and acetonitrile, and dried under vacuum to give 2-[5-carboxy-1H-benzimidazol-2(3H)-ylidene]-2-(3-trifluoromethylpyrimidin-2-yl)acetonitrile (450 mg, 1.29 mmol, 55% yield) as a brown solid.The 2-[5-carboxy-1H-benzimidazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)-acetonitrile (450 mg, 1.29 mmol) from the previous step, dissolved in concentrated sulfuric acid (2 mL), was heated to 50 C. for 6 hr. The mixture was cooled to room temperature and added dropwise to rapidly stirred room-temperature water (500 mL). The precipitate that formed was collected by filtration, washed with water, and dried under vacuum to give 2-[5-carboxy-1H-benzimidazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)acetamide (322 mg, 0.88 mmol, 68% yield) as a dark brown solid.To a room temperature solution of 2-[5-carboxy-1H-benzimidazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)acetamide (630 mg, 1.73 mmol) in dimethylformamide (20 mL) was added DIPEA (661 muL, 3.79 mmol, 2.2 eq.), HBTU (720 mg, 1.90 mmol, 1.1 eq.). After 5 min, 3-(4-morpholinyl)propan-1-amine (277 muL, 1.90 mmol, 1.1 eq.) was added and the mixture was stirred at room temperature for 3 hr. The mixture was diluted with EA (50 mL) and washed three times with 5% aqueous sodium bicarbonate (50 mL each). The EA fraction was decanted, dried over magnesium sulfate, filtered, and concentrated under vacuum to give a yellow solid. About 2 mL of 4.0 M hydrogen chloride in dioxane was added, and the mixture was stirred for 15 min and then concentrated under vacuum to give 2-(5-[3-(4-morpholinyl)propyl]aminocarbonyl}-1H-benzimidazol-2(3H)-ylidene)-2-(4-trifluoromethylpyrimidin-2-yl)acetamide hydrochloride (750 mg, 1.52 mmol, 88% yield) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | A mixture of 4-amino-3-mercaptobenzoic acid (768 mg, 4.5 mmol), 3,3-bis(methylthio)-2-(4-trifluoromethylpyrimidin-2-yl)acrylonitrile (1.45 g, 5.0 mmol, 1.1 eq.), 4-dimethylaminopyridine (550 mg, 4.5 mmol, 1 eq.), and potassium carbonate (622 mg, 4.5 mmol, 1 eq.) in ethanol (20 mL) was heated at 160 C. for 0.4 hr in a microwave. The mixture was cooled to room temperature, diluted with DCM, and washed with 1M hydrochloric acid. The DCM fraction was decanted, filtered, and concentrated under vacuum to give 2-[6-carboxybenzothiazol-2(3H)-ylidene]-2-(4-trifluoromethyl-pyrimidin-2-yl)acetonitrile (729 mg, 40% yield) as a brown solid.A solution of 2-[6-carboxybenzothiazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)-acetonitrile (620 mg, 1.70 mmol) in concentrated sulfuric acid (5 mL), was heated to 50 C. for 10 hr. The mixture was cooled to room temperature and added dropwise to rapidly stirred room-temperature water (100 mL). The precipitate that formed was collected by filtration, washed with water and hexanes, and dried under vacuum to give 2-[6-carboxybenzothiazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)acetamide (587 mg, 90% yield) as a brown solid.To a room temperature solution of 2-[6-carboxybenzothiazol-2(3H)-ylidene]-2-(4-trifluoromethylpyrimidin-2-yl)acetamide (350 mg, 0.92 mmol) in acetonitrile (5 mL) was added triethylamine (250 muL, 1.79 mmol, 2 eq.), DEPBT (299 mg, 1.0 mmol, 1.1 eq.), and 3-(4-morpholinyl)-propan-1-amine (134 muL, 0.92 mmol, 1.0 eq.), and the mixture was stirred at room temperature until a yellow-brown precipitate formed. The precipitate was collected by filtration, washed with acetonitrile, and dried under vacuum to give a yellow solid. About 2 mL of 4.0 M hydrogen chloride in dioxane was added, and the mixture was stirred for 15 min and then concentrated under reduced pressure to give 2-(6-[3-(morpholin-4-yl)propyl]aminocarbonyl}-benzothiazol-2(3H)-ylidene)-2-(4-trifluoromethyl-pyrimidin-2-yl)acetamide hydrochloride (340 mg, 73% yield) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; | Step 5: Synthesis of 2-(2-methoxypyridin-3-yl)-N-(3-morpholinopropyl)-1H-indole-5-carboxamide (5) To a solution of 2-(2-methoxypyridin-3-yl)-1H-indole-5-carboxylic acid (0.850 g, 0.317 mmol) in dimethylformamide (5 ml) was added HBTU (1.20 g, 0.317 mmol) and N,N-diisopropylethylamine (0.70 ml, 0.519 g, 0.402 mmol). The reaction mixture was allowed to stir for five minutes and 3-morpholinopropan-1-amine (0.59 ml) was added. The reaction was allowed to stir for 2 hours at room temperature. The reaction was quenched by adding water (25 ml), saturated sodium bicarbonate solution (25 ml) and extracted with EtOAc (2×50 ml). The organic extracts were combined, washed with brine (1×25 ml), dried over sodium sulfate and concentrated. The crude product was purified by flash column chromatography (SiO2, 100% EtOAc to 3% MeOH in EtOAc) to give the desired product as a white solid (1.09 g, 87%). M.p.=224-225 C.; 400 MHz 1H NMR (DMSO-d6) delta: 11.55 (s, 1H), 8.36 (t, J=5.4 Hz, 1H), 8.23 (dd, J=1.6 Hz, 7.6 Hz, 1H), 8.17 (dd, J=2.0 Hz, 5.2 Hz, 1H), 8.11 (s, 1H), 7.65 (dd, J=2 Hz, 8.4 Hz, 1H), 7.47 (d, J=8.4, 1H), 7.18-7.12 (m, 2H), 4.06 (s, 3H), 3.60-3.56 (m, 4H), 3.35-3.27 (m, 2H), 2.38-2.31 (m, 6H), 1.76-1.66 (m, 2H); LCMS: 395 [M+H]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With imidazole-1-sulfonyl azide hydrochloride; copper(ll) sulfate pentahydrate; potassium carbonate; In methanol; at 20℃; | General procedure: Imidazole-1-sulfonyl azide hydrochloride (2.343 g, 11.21 mol) was added to the phenylmethanamine (1.0 g 9.345 mol), K2CO3 (2.57 g, 18.69 mol) and CuSO4.5H2O (2.5 mg, 10 mumol) in MeOH (5 mL) and the mixture stirred at room temperature for 6-16 h. Then filter through celite bed filtrate was evaporated gave the crude azide was used without purification for next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With hydrazine hydrate; In ethanol; for 24h;Reflux; | General procedure: To a solution of compounds 6b-l (9.15 mmol) in 30 mLEtOH was added hydrazine monohydrate (36.6 mmol; 4 eq.) andthe mixture was vigorously stirred under reflux for 24 h. The whitesolid was filtered off and washed with EtOH. Filtrate was concentratedunder vacuum to dryness and taken up with EtOAc. The solidresidue was filtered again and filtrate was concentrated in vacuo toafford the desired products 7b-7l. NH2 signals are missing for allcompounds in 1H NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 130℃; for 16h; | A solution of 6-bromo-2-chloroquinoline (100 mg, 0.412 mmol), [3-(4- morpholinyl)propyl]amine (178 mg, 1 .237 mmol) and DIPEA (216 muIota, 1.237 mmol) in N-Methyl-2- pyrrolidone (NMP) was maintained at 130C for 16 hours. The solution was cooled, poured into water and extracted with ethyl acetate. The organic layer was separated, dried over sodium sulfate, filtered, taken to a residue under reduced pressure and purified by columnchromatography to afford intermediate 6-bromo-N-[3-(4-morpholinyl)propyl]-2-quinolinamine (120 mg, 0.343 mmol, 83 % yield) as a white solid. A solution of 6-bromo-N-[3-(4- morpholinyl)propyl]-2-quinolinamine (120 mg, 0.343 mmol), 2,4-difluoro-N-[2-(methyloxy)-5- (4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-3-pyridinyl]benzenesulfonamide (197 mg, 0.463 mmol), Pd(Ph3P)4 (39.6 mg, 0.034 mmol) and potassium carbonate (142 mg, 1.028 mmol) in 1 ,4-dioxane (2 ml_)/Water (2.0 ml.) was maintained at 80C for 2 hours. The mixture was cooled, poured into ethyl acetate and washed with water. The organic layer was separated, dried over sodium sulfate, filtered and taken to a residue under reduced pressure to afford 2,4- difluoro-N-[2-(methyloxy)-5-(2-[3-(4-morpholinyl)propyl]amino}-6-quinolinyl)-3- pyridinyl]benzenesulfonamide (72 mg, 36.9 % yield) as a white solid following column chromatography. 1 H NMR (DMSO-d6) delta: 10.24 (br. s., 1 H), 8.34 (d, J = 2.3 Hz, 1 H), 7.87 - 7.92 (m, 2H), 7.85 (d, J = 2.0 Hz, 1 H), 7.74 - 7.80 (m, 1 H), 7.72 (dd, J = 8.9, 2.2 Hz, 1 H), 7.50 - 7.61 (m, 2H), 7.18 - 7.25 (m, 1 H), 7.15 (t, J = 5.3 Hz, 1 H), 6.79 (d, J = 9.0 Hz, 1 H), 3.64 (s, 3H), 3.56 - 3.63 (m, 4H), 3.39 - 3.47 (m, 2H), 2.35 - 2.47 (m, 6H), 1 .77 (quin, J = 7.0 Hz, 2H). LCMS (m/z, ES+) = 570 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
56.8% | Preparation of tert-butyl 4-((lR,3aS,5aR,5bR,7aR,l laS,l lbR,13aR,13bR)- 5a,5b,8,8,l la-pentamethyl-3a-((3-morpholinopropylamino)methyl)-l-(prop-l-en-2- yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,l l,l la,l lb,12,13,13a,13b-octadecahydro-lH- cyclopenta[a]chrysen-9-yl)benzoate.To a solution of ter/-butyl 4-((lR,3aS,5aR,5bR,7aR,l laS,l lbR,13aR,13bR)-3a- formyl-5a,5b,8,8,l la-pentamethyl-l-(prop-l-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,l l,l la,l lb,12,13,13a,13b-octadecahydro-lH- cyclopenta[a]chrysen-9-yl)benzoate (0.1 g, 0.167 mmol) in DCE (2 ml) was added acetic acid (1M in DCM) (0.167 ml, 0.167 mmol) and N-(3-Aminopropyl)morpholine (0.029 ml, 0.200 mmol). The mixture was stirred for 15 minutes at rt and sodium triacetoxyborohydride (0.071 g, 0.334 mmol) was added. The mixture was stirred at rt for 1.5 h and an additional 0.1 g of sodium triacetoxyborohydride was added. The mixture was stirred overnight at rt then was quenched with 7 ml of sat. NaHC(¾. The mixture was extracted with dichloromethane (3 x 7 ml) and the combined organic layers were dried with a2S04. The drying agent was removed by filtration and the filtrate was concentrated under reduced pressure. The mixture was purified by flash chromatography using a 0-10% MeOH in dichloromethane gradient. The fractions containing the expected product were combined and concentrated under reduced pressure to give the title compound as a white foam (69 mg, 0.095 mmol, 56.8 % yield). LCMS: m/e 727.5 (M+H)+, 2.81 min (method 6). | |
General procedure: A suspension oftert-butyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-formyl-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate5(1 eq.), the corresponding amine (2 eq.) and acetic acid (2 - 5 eq.) in DCE (2 ml) was stirred at RT for 30 min.To this suspension was added sodium triacetoxyborohydride (5 eq.).The resulted mixture was stirred at RT for 18 - 72 hrs.The reaction mixture was diluted with 5 ml of saturated sodium carbonate and extracted with DCM (3 x 10 ml).The combined organic layers were dried over sodium sulfate, filtered and concentratedinvacuo.The crude product was purified by Biotage flash chromatography or was used directly in the next step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; for 12h;Inert atmosphere; | General procedure: In a 50 mL two necked round flask were placed at room temperature under argon geranic acid 1 (250 mg, 1.5 × 10-3 mol) and 1,2-ethylenediamine (90 mg, 1.5 × 10-3 mol) in anhydrous CH2Cl2 (15 mL). The mixture was placed under stirring and diisopropylethylamine (195 muL, 1.5 × 10-3 mol) was slowly added, followed by the addition of the coupling reagent (BOP) (780 mug, 1.5 × 10-3 mol) dissolved in 5 mL of anhydrous CH2Cl2. The reaction was stirred for 12 h at 20 C. After removal of the solvents, the crude residue was purified by chromatography on a silicagel column using CH2Cl2/MeOH/NH4OH (7:3:1) eluent affording the expected coupling product 3 in 75% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In N,N-dimethyl-formamide; at 170℃; for 3h; | General procedure: A mixture of 2 (0.6 mmol), amine (0.7 mmol), K2CO3 (1.2 mmol), and Pd(PPh3)4 (0.05 mmol) was heated in 10 ml DMF for 3 h at 170 C. The residue was purified by column chromatography on silica gel to afford the product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With N-ethyl-N,N-diisopropylamine; In iso-butanol; at 120℃; for 0.5h;Microwave irradiation; | 4Synthesis of EHop-016 [0031] 1H and 13C NMR spectra were recorded on a Bruker 400 MHz Spectrometer. Mass spectra were obtained on a Hewlett Packard 6890N GC/MS Spectrometer. All chemicals were purchased from Sigma Aldrich Chemical Company. The synthesis of EHop-016 (5) was performed in two steps according to the reaction scheme provided in FIG. 1(A), and carried out analogous to the procedure described in (58). (2-Chloro-pyrimidin-4-yl)-(9-ethyl-9H-carbazol-3-yl)-amine 3 was obtained as a pure compound in a yield of 53%. The product was identified with TLC, NMR and GC/MS. Rf=0.23 (3:1, Hexane-Ethyl Acetate); 1H NMR (DMSO-d6, 400 MHz) delta 1.32 (t, J=6.9 Hz, 3H), 4.45 (q, J=6.6 Hz, 2H), 6.72 (s, 1H), 7.20 (t, J=7.36 Hz, 1H), 7.47 (t, J=7.30 Hz, 1H), 7.56 (s, 1H), 7.62 (t, J=8.68 Hz, 1H), 8.11 (t, J=7.36 Hz, 1H), 8.27 (s, 1H), 10.1 (s, 1H); 13C (DMSO-d6, 100 MHz) delta 13.7, 37.0, 109.2, 109.4, 115.0, 118.7, 120.3, 121.3, 121.9, 122.3, 125.9, 129.9, 136.9, 140.0, 156.9, 159.6, 162.4; LRGC-MS m/z (rel %):[M]+ 276 (100), [M-Cl]+ 241 (40), [M-C5H5N3Cl]+ 134 (26). N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-yl-propyl)-pyrimidine-2,4-diamine 5 (EHop-016) was obtained as a pure compound in a yield of 93%. The product was identified to be essentially pure by TLC and NMR: Rf=0.34 (9:1, CH2Cl2-MeOH); 1H NMR (DMSO-d6, 400 MHz) delta 1.31 (t, J=7.0 Hz, 3H), 1.73 (m, 2H), 2.32 (m, 2H), 2.34 (t, J=6.89 Hz, 8H), 3.52 (m, 2H), 4.42 (q, J=7.0 Hz, 2H), 5.98 (d, J=5.7 Hz, 1H), 6.69 (t, J=5.3 Hz, 1H), 7.16 (t, J=7.4, 1H), 7.43 (t, J=7.2 Hz, 1H), 7.53 (t, J=9.0 Hz, 4H), 7.81 (d, J=5.4 Hz, 1H), 8.10 (s, 1H), 8.66 (s, 1H), 9.1 (s, 1H); 13C (DMSO-d6, 100 MHz) delta 13.7, 26.2, 36.9, 53.4, 56.3, 66.2, 108.9, 109.0, 118.2, 119.7, 120.2, 122.0, 122.2, 125.6, 132.5, 135.5, 139.9, 159.8, 160.9, 162.1. |
52.1% | With caesium carbonate; In 1,4-dioxane; at 120 - 160℃; | For the synthesis of EHop-016 derivatives with modifications in building block C, an optimized procedure for the synthesis of EHop-016 was utilized (see U.S. Pat. No. 8,884,006, herein incorporated in its entirety). FIG. 11A describes Scheme 1B, a two-step synthetic procedure for the synthesis of EHop-016 and derivatives. The two-step synthetic scheme starts in ?step a? with the synthesis of EHop-014 (3) from dichloropyrimidine (1) and 3-amino-9-ethyl-carbazole (2). In the optimized procedure, first dichloropyrimidine as obtained from the supplier, is purified by slurrying in ethyl acetate for one hour. Insoluble solids (hydrolyzed impurities) are filtered and the ethyl acetate is removed via rotary evaporation. Subsequently, purified 1 is reacted with carbazole 2 via reflux in tetrahydrofuran in the presence of 1.2 equivalents triethyl amine. Compared with the previous method, workup was simplified by addition of water and ethyl acetate, which led to the precipitation of 3. Filtration over a Buechner funnel provided compound 3 without column chromatography as essentially the single 4-substituted regioisomer in a yield of 52.1%. Reaction of product 3 with different amines representing building block C, in the presence of either cesium carbonate or triethylamine amine in dioxane or dimethyl sulfoxide under microwave heating at 120 to 160 C. (step b) provided the desired EHop-016 derivatives. A summary of the products synthesized, together with their yields is provided in Table 4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | Example 172 7-(3-[(3-isopropylphenyl)amino]carbonyl}phenyl)-N-(3-morpholin-4-ylpropyl)-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carboxamide To a mixture of 7-(3-[(3-isopropylphenyl)amino]carbonyl}phenyl)-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carboxylic acid (25 mg, 0.06 mmol), triethylamine (0.017 mL, 0.12 mmol), and catalytic DMAP in 1.1 mL 1,2-dichloroethane at rt was added propylphosphonic anhydride solution (50 wt % in EtOAc, 0.043 mL, 0.072 mmol). After 5 min at rt, 3-morpholinopropylamine (0.011 mL, 0.072 mmol) was added and the reaction stirred at rt for 1.5 hours. The reaction was partitioned between EtOAc and brine/aqueous NaHCO3 solution, the EtOAc layer washed with brine/aqueous NaHCO3 solution, dried with anhydrous Na2SO4 and rotary evaporated. This material was chromatographed eluting with CHCl3/MeOH to give the title compound as an off-white solid (17 mg, 54%). 1H NMR (CDCl3) delta: 8.50 (s, 1H), 8.48 (s, 1H), 7.83-7.92 (m, 2H), 7.54 (d, J=4.7 Hz, 2H), 7.46 (d, J=8.2 Hz, 1H), 7.34-7.41 (m, 1H), 7.20-7.33 (m, 2H), 7.13 (d, J=7.9 Hz, 1H), 7.03 (d, J=7.3 Hz, 1H), 4.50 (s, 2H), 3.52-3.63 (m, 8H), 3.23 (t, J=5.7 Hz, 2H), 2.87-2.98 (m, 1H), 2.56 (t, J=6.0 Hz, 2H), 2.47 (br. s., 4H), 1.75-1.85 (m, 2H), 1.27 (d, J=7.0 Hz, 6H) | |
54% | Example 172 7-(3-[(3-isopropylphenyl)amino]carbonyl}phenyl)-N-(3-morpholin-4-ylpropyl)-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carboxamide To a mixture of 7-(3-[(3-isopropylphenyl)amino]carbonyl}phenyl)-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carboxylic acid (25 mg, 0.06 mmol), triethylamine (0.017 mL, 0.12 mmol), and catalytic DMAP in 1.1 mL 1,2-dichloroethane at rt was added propylphosphonic anhydride solution (50 wt % in EtOAc, 0.043 mL, 0.072 mmol). After 5 min at rt, 3-morpholinopropylamine (0.011 mL, 0.072 mmol) was added and the reaction stirred at rt for 1.5 hours. The reaction was partitioned between EtOAc and brine/aqueous NaHCO3 solution, the EtOAc layer washed with brine/aqueous NaHCO3 solution, dried with anhydrous Na2SO4 and rotary evaporated. This material was chromatographed eluting with CHCl3/MeOH to give the title compound as an off-white solid (17 mg, 54%). 1H NMR (CDCl3) delta: 8.50 (s, 1H), 8.48 (s, 1H), 7.83-7.92 (m, 2H), 7.54 (d, J=4.7 Hz, 2H), 7.46 (d, J=8.2 Hz, 1H), 7.34-7.41 (m, 1H), 7.20-7.33 (m, 2H), 7.13 (d, J=7.9 Hz, 1H), 7.03 (d, J=7.3 Hz, 1H), 4.50 (s, 2H), 3.52-3.63 (m, 8H), 3.23 (t, J=5.7 Hz, 2H), 2.87-2.98 (m, 1H), 2.56 (t, J=6.0 Hz, 2H), 2.47 (br. s., 4H), 1.75-1.85 (m, 2H), 1.27 (d, J=7.0 Hz, 6H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In dichloromethane; at 20℃; for 18h;Cooling with ice; | [00097] N-(3-morpholinopropyl)-4-(undec-l-ynyl)picolinamide (CYD-1-42). To a solution of CYD-1-10 (100 mg, 0.36 mmol), triethylamine (147 mg, 1.46 mmol) and 3- morpholinopropan-1 -amine (68.5 mg, 0.47 mmol) in 10 mL of CH2C12 was added HBTU (276 mg, 0.73 mmol) in an ice-water bath. The reaction mixture was stirred at room temperature for 18 hrs. TLC indicated that the starting material was gone, and a less polar product was produced. The reaction mixture was diluted with CH2C12, washed with water and brine, and dried with anhydrous Na2S04. The solvent was removed under vacuum to give an oil residue. The residue was purified by silica gel column; eluting with 2%> Et3N in EtOAc afforded CYD-1-42 (125.0 mg, 85%) as a colorless oil; 1H NMR (600 MHz, CDC13) delta 8.94 (s, 1H), 8.46 (d, 1H, J= 4.8 Hz), 8.14 (s, 1H), 7.35 (m, 1H), 3.79 (m, 4H), 3.57 (m, 2H), 2.48 (m, 8H), 1.80 (m, 2H), 1.61 (m, 2H), 1.44 (t, 2H, J = 7.2 Hz), 1.29 (m, 10H), 0.88 (t, 3H, J= 7.2 Hz). |
85% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In dichloromethane; at 20℃; for 18h;Cooling with ice; | To a solution of CYD-1-10 (100 mg, 0.36 mmol), triethylamine (147 mg, 1.46 mmol) and 3-morpholinopropan-1-amine (68.5 mg, 0.47 mmol) in 10 mL of CH2Cl2 was added HBTU (276 mg, 0.73 mmol) in an ice-water bath. The reaction mixture was stirred at room temperature for 18 hrs. TLC indicated that the starting material was gone, and a less polar product was produced. The reaction mixture was diluted with CH2Cl2, washed with water and brine, and dried with anhydrous Na2SO4. The solvent was removed under vacuum to give an oil residue. The residue was purified by silica gel column; eluting with 2% Et3N in EtOAc afforded CYD-1-42 (125.0 mg, 85%) as a colorless oil; 1H NMR (600 MHz, CDCl3) delta 8.94 (s, 1H), 8.46 (d, 1H, J=4.8 Hz), 8.14 (s, 1H), 7.35 (m, 1H), 3.79 (m, 4H), 3.57 (m, 2H), 2.48 (m, 8H), 1.80 (m, 2H), 1.61 (m, 2H), 1.44 (t, 2H, J=7.2 Hz), 1.29 (m, 10H), 0.88 (t, 3H, J=7.2 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | To a solution of (S)-7 (2.28 g, 8.0 mmol) in DCM (60 mL), DEPBT (2.40 g, 8.0 mmol) and DIPEA (2.78 mL, 16.0 mmol) were added and reaction mixture was stirred at room temperature for 5 min. 3-Morpholinopropylamine 8c (1.17 mL, 8.0 mmol) was added to the reaction mixture and it was stirred at room temperature for 20 H. Mixture was quenched with H2O (60 mL) and organic layer was washed with brine (2x60 mL), dried over Na2SO4 filtered and evaporated. The residue was purified by flash column chromatography eluting with DCM : MeOH (95 : 5) to afford 2.12 g of the titled compound 9c as a white solid (65 %): mp 131-132 C; [alpha]D20+ 52.4 (c 1, MeOH); deltaH (400 MHz; CDCl3) 7.39-7.29 (10H, m), 7.14-7.13 (1H, m), 6.26 (1H, d, J = 5.7 Hz), 5.15 (1H, d, J = 6.0 Hz), 5.11-5.04 (2H, m), 3.63-3.56 (4H, m), 3.36-3.31 (2H, m), 2.33-2.22 (6H, m), 1.60-1.59 (2H,m); 13C NMR (300 MHz; CDCl3) 170.3, 156.5, 139.4, 137.1, 129.8, 129.3, 129.0, 128.9, 128.2, 67.8, 67.7, 59.7, 58.4, 54.5, 54.3, 40.6, 25.2; HR-MS [M + H]+ observed = 412.2243, calculated = 412.2231. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | General procedure: To a stirred solution of 4-((2-(2,6-dichlorobenzyl)-1H-benzo[d]imidazol-1-yl)methyl)benzoic acid 35 (1.0 equiv) in CH2Cl2 wasadded oxalyl chloride (2.0 equiv) dropwise at room temperature.After catalytic amount of DMF (0.2 equiv) was added, the reactionmixture was stirred for 2 h at room temperature. And then, thereaction mixture was concentrated in vacuo. To the resulting residuewas added a mixture of the desired substituted amine(1.2 equiv) and DIPEA (2.5 equiv) in THF. The reaction mixture wasstirred at room temperature for 16 h, concentrated in vacuo, andextracted with CH2Cl2 (3 x 30 mL). The organic layerwas dried overanhydrous Na2SO4, filtered, concentrated, and purified by columnchromatography on SiO2 (CH2Cl2/MeOH: 10/1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With dmap; In chloroform; at 25℃; | General procedure: To a solution of 2-oxo-2H-chromene-3-carbonyl chloride 3 (2mmol) and DMAP (4-dimethylaminopyridine, 2mmol) in chloroform (30mL) at 10C was added dropwise substituted amines (3.0mmol) for 30min. The reaction mixture was stirred at room temperature for 2-3h and washed with 20mL H2O, 10mL 1% NaHCO3, respectively, then dried on anhydrous MgSO4. The solvent was removed in vacuo and the crude residue was purified by chromatography on SiO2 (acetone/petroleum, 4: 1, v/v) to give title compounds 4a-4t as a colorless solid. Compounds 1-3 were prepared according to references [14,17]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With dmap; In chloroform; at 25℃; | General procedure: To a solution of 2-oxo-2H-chromene-3-carbonyl chloride 3 (2mmol) and DMAP (4-dimethylaminopyridine, 2mmol) in chloroform (30mL) at 10C was added dropwise substituted amines (3.0mmol) for 30min. The reaction mixture was stirred at room temperature for 2-3h and washed with 20mL H2O, 10mL 1% NaHCO3, respectively, then dried on anhydrous MgSO4. The solvent was removed in vacuo and the crude residue was purified by chromatography on SiO2 (acetone/petroleum, 4: 1, v/v) to give title compounds 4a-4t as a colorless solid. Compounds 1-3 were prepared according to references [14,17]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With dmap; In chloroform; at 25℃; | General procedure: To a solution of 2-oxo-2H-chromene-3-carbonyl chloride 3 (2mmol) and DMAP (4-dimethylaminopyridine, 2mmol) in chloroform (30mL) at 10C was added dropwise substituted amines (3.0mmol) for 30min. The reaction mixture was stirred at room temperature for 2-3h and washed with 20mL H2O, 10mL 1% NaHCO3, respectively, then dried on anhydrous MgSO4. The solvent was removed in vacuo and the crude residue was purified by chromatography on SiO2 (acetone/petroleum, 4: 1, v/v) to give title compounds 4a-4t as a colorless solid. Compounds 1-3 were prepared according to references [14,17]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | General procedure: Rifaldehyde (290.0 mg, 0.4 mmol) was dissolved in 30 mL CH2Cl2 and after the addition of catalyst (0.2 mmol ZnCl2 or 0.02 mmol HCl/EtOH) respective mixtures were made with each of the following compounds taken separately: propargylamine, 3-azidopropylamine, 2-azidoethylamine, (1-(2-aminoethyl)piperidine, 1-(2-aminoethyl)pyrrolidine, N,N-dimethylethylenediamine, 1-(3-aminopropyl)-imidazole, 3-morpholinopropyl-amine, 4-aminobenzylpiperidine, 1-(3-aminopropyl)pyrrolidine or 3-(dimethylamino)-1-propylamine, 3-(diethylamino)propyl-amine) (0.41 mmol) in 5 mL of C2H5OH. The mixtures were stirred at 45 C for half an hour and after that a half of the solvent volume was distilled off. To the cooled reaction mixture (room temperature) the reductant NaBH4 (6.8 mg, 0.18 mmol) was added portionwise over 1 min. The reaction mixture was evaporated to dryness, dissolved in 50 mL of ethyl acetate and extracted twice with 50 mL of water and brine. The separated organic layer was evaporated and synthesised derivatives of <strong>[13292-22-3]<strong>[13292-22-3]3-formylrifamycin</strong> SV</strong> (compounds 1-12) were then purified by column chromatography with silica gel (25 cm×1 cm, silica gel 60, 0.040-0.063 mm/230-400 mesh ASTM, Fluka) and ethyl acetate/methanol was applied as eluent (from 100:0 to 15:1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | A solution of 6-nitrobenzo[d]oxazole-2-thiol (KR-200) (13.61 mmol, 2.67 g)in dichloromethane (454 mL) and oxalyl chloride (17.01 mmol, 1.46 mL) wasplaced under argon atmosphere and cooled to 0 ?C. Dimethylformamide (15 mL) was added drop wise over a period of 45 minutes. CAUTION: The addition of dimethylformamide should be conducted slowly to avoid rapid evolution of gas. The reaction was stirred for 30 minutes at 0 ?C, then ice bath was removed and the reaction was allowed to warm to room temperature. After two hours, the reaction was again cooled to 0 ?C and triethylamine (40.83 mmol, 5.69 mL) was added drop wise over a period of 25 minutes. Then 3-morpholinopropan-1-amine (KR-347) (14.97 mmol, 2.16 g) was added, and the ice bath was removed. The reaction was stirred for twenty hours at room temperature then concentrated in vacuo yielding an orange solid. Silica gel column chromatography of the solid (20:1 dichloromethane/methanol) provided pure KR-202347 as a yellow powder in a 70% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
for 2h;Reflux; | 4-(3-Aminopropyl)morpholine (0.115 g, 0.8 mmol) was added to methanolic solution (20 mL) of DFP (0.065 g, 0.4 mmol) and the resulting solution was stirring for 15 min and then refluxed for 2 h. This ?solution of HL2? was used for subsequent reactions without isolation and further purification or characterization. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | In methanol; water; for 0.5h; | General procedure: To a solution of <strong>[520-33-2]hesperetin</strong> 2 (1.82mmol) in MeOH (40mL) was added 37% formaldehyde-water (150muL, 1.82mmol, 1.0equiv), after vigorous stirring at 30C for 30min, different amines (2.00mmol, 1.1equiv) were added and the mixture was stirred overnight. The reaction was monitored by TLC. The mixture was concentrated in vacuo and the residue was purified by silica gel column chromatography (CH2Cl2/MeOH, 5:1?3:1) to give title compounds 3a-3p (yields 47-80%, Scheme 1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With triethylamine; In butan-1-ol; at 90℃; for 12h; | General procedure: A mixture of 2-amino-4,6-dichloropyrimidine (1) (5 g, 30.5 mmol), the appropriate amine 2a or 2b (33.5 mmol), and triethylamine (152 mmol) in 150 mL n-butanol was heated to 90 C for 12 h. After cooling, the solvent was removed in vacuo, and the residue was partitioned between saturated aqueous Na2CO3 solution and ethyl acetate. The ethyl acetate layer was washed with brine, dried over anhydrous Na2SO4 and concentrated. The residue was purified by column chromatography using the suitable mobile phase to afford the corresponding compounds 2a or 2b. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | General procedure: A round-bottom flask containing the 1H-indole-2-carbaldehyde34or <strong>[53590-49-1]5-chloro-1H-indole-2-carbaldehyde</strong>35 (1 eq.), the desiredamine (1 eq.) and anhydrous Na2SO4 (6 eq.) in CH2Cl2 was stirredovernight at room temperature. The reaction was filtered and thesolvent removed under reduced pressure. The residue was solubilizedin anhydrous MeOH and 2 eq. of NaBH4 were added in an icebath. After the addition, the ice bath was removed and the reactionwas kept under magnetic stirring at room temperature until thecompletion of the reaction was detected by TLC (1-2 h). The reactionwas quenched with distilled water, the MeOH was removedunder reduced pressure and the resulting aqueous phase wasextracted with 2 15 mL AcOEt. The organic layers were combinedand extracted with a 0.3 M HCl solution and the aqueouslayer was collected, alkalinized with 1 M NaOH and extracted with2 15 mL AcOEt. Finally, the organic layer was dried with Na2SO4,filtered and the solvent evapored under reduced pressure |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | In water; at 100℃; for 24h; | General procedure: To a solution of primary amines 7a-l (2 eq) inwater (0.5 mol/L) wasadded O-methylisourea bisulfate (1 eq). Solution was stirred at 100 C for 24 h. After concentration to dryness, ethanol was addedand the residue was sonicated until apparition of a precipitate. Insome difficult cases, the suspension in ethanol was stored overnightin a freezer and triturated with cold ethanol to get a powder.Addition of a few drops of diethylether was also occasionallyneeded to induce precipitation. The solids 8a-l were collected byfiltration, washed with ethanol and dried overnight under vacuum.Due to the hygroscopicity of isolated solids, no melting points weredetermined for these series. NH signals are missing for all compoundsin 1H NMR spectra. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In acetonitrile; at 80℃; for 5h; | General procedure: To a solution of 2a-j (10 mmol, 1.0 eq) , <strong>[87486-34-8]3,5-dibromo-1-methylpyrazin-2(1H)-one</strong> (2.95 g, 11 mmol, 1.1 eq) and DIEA (3.3 mL,20 mmol, 2.0 eq) in MeCN (20mL) was stirred at 80 °C for 5 hours. After cooling to room temperature, thesolvent was removed in vacuo, and the residue was purified using silica gelchromatography to give the title compounds, yield 72-85percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; In N,N-dimethyl-formamide; at 20℃; | General procedure: The synthetic pathways for the preparation of compounds 6h-m are depicted in Scheme S3. In a 25 mL round bottom flask, compound 7 (185 mg, 1 mmol) was dissolved in SOCl2 (6 mL) and heated to 50 C for 4-5 h. The progress of the reaction was monitored by TLC, and the reaction solution concentrated by rotary evaporation after completion of the reaction. The obtained acid chloride compound was dissolved in dry DMF, and diphenylmethanamine (8a, 219 mg, 1.2 mmol) and DMAP (61 mg, 0.5 mmol) were added, and the reaction was allowed to stand overnight. After completion of the reaction, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed three times with saturated aqueous NaCl, and dried over anhydrous Na2SO4. N-Benzhydryl-5-fluoro-2-nitrobenzamide (9a), yield 72%. |
Tags: 123-00-2 synthesis path| 123-00-2 SDS| 123-00-2 COA| 123-00-2 purity| 123-00-2 application| 123-00-2 NMR| 123-00-2 COA| 123-00-2 structure
[ 141814-57-5 ]
(4-Methylmorpholin-2-yl)methanamine
Similarity: 0.89
[ 122894-56-8 ]
N,N-Dimethyl-1-(morpholin-2-yl)methanamine
Similarity: 0.89
[ 108302-54-1 ]
N-Ethyl-2-morpholinoethanamine
Similarity: 0.77
[ 70384-51-9 ]
Tris(2-(2-methoxyethoxy)ethyl)amine
Similarity: 0.76
[ 141814-57-5 ]
(4-Methylmorpholin-2-yl)methanamine
Similarity: 0.89
[ 122894-56-8 ]
N,N-Dimethyl-1-(morpholin-2-yl)methanamine
Similarity: 0.89
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :